tradingkey.logo
tradingkey.logo
Search

Neurosense's Drug Candidate Shows Early Signals Of Benefit In Alzheimer's Patient-Derived Neurons

ReutersSep 10, 2025 6:42 PM
facebooktwitterlinkedin

- Neurosense Therapeutics Ltd NRSN.O:

  • NEUROSENSE'S DRUG CANDIDATE SHOWS EARLY SIGNALS OF BENEFIT IN ALZHEIMER'S PATIENT-DERIVED NEURONS

  • NEUROSENSE THERAPEUTICS- INITIAL PHASE 2 ROAD TRIAL RESULTS DEMONSTRATE IMPROVEMENTS IN BRAIN-CELL CONNECTIVITY HEALTH, WITH FAVORABLE SAFETY PROFILE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI